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ABSTRACT 
Introduction: Madhumegam is a clinical condition characterised by frequent and excessive 
urination which ultimately leads to deterioration of seven body constituents and three 
humours. Its signs and symptoms may be correlated with Diabetes mellitus in modern science. 
Since, metabolic syndrome has become major cause of morbidity and mortality, identifying its 
cause and prevention has gained immense importance. 
Aim: This study aimed at determining the prevalence of metabolic syndrome in Madhumegam 
(Type 2 Diabetes mellitus) patients and to identify the most critical predictive risk factors of 
metabolic syndrome. 
Methods: This hospital based cross sectional study involved 100 type 2 diabetes mellitus 
patients and was conducted at Ayothidoss Pandithar Hospital, National Institute of Siddha. 
This study used questionnaire to obtain information on diabetic condition, anthropometric 
measurements and lipid profile. Metabolic syndrome was defined according to the 
International Diabetes Federation criteria.  
Results: The prevalence of metabolic syndrome was 53% in the study population. Elevated 
triglyceride was the commonest component (77.3%) followed by lowered HDL (51%). Female 
type 2 diabetic patients had a higher prevalence of metabolic syndrome (54.7%) than their 
male counterparts (45.3%). With respect to age, individual within the age group of 60-69 had 
highest prevalence of metabolic syndrome while age group of 30-39 has least prevalence of 
metabolic syndrome. 
Conclusion: Elevated triglyceride for men and lowered HDL for women were the strongest 
risk factors. Metabolic syndrome is a significant health problem and its preventive strategies 
should focus on early diagnoses and lifestyle modification. 
KEYWORDS: Madhumegam, Diabetes mellitus, Metabolic syndrome, International Diabetes 
Federation. 
INTRODUCTION 
Madhumegam is a clinical condition 
characterised by frequent and excessive urination 
which ultimately leads to deterioration of seven body 
constituents and three humours.[1,2] In the text 
Therankarisal, Madhumegam is categorized under 
Neerinai perukkal noi. The signs and symptoms of 
Madhumegam are polydipsia, polyphagia, polyurea, 
fatigue, mood swings and insomnia. Its signs and 
symptoms may be correlated with Diabetes mellitus 
in modern science.  
 Diabetes mellitus is a metabolic disease 
characterised by hyperglycemia resulting from 
defects in insulin secretion, insulin action, or both. [3] 
India has the second highest burden of adult diabetes 
in the world after China.[4] Rapid socio-economic 
transition with urbanisation and industrialisation are 
the main causes for global diabetes epidemic.  
According to International Diabetes 
Federation, the Metabolic Syndrome is a cluster of 
cardiovascular risk factor such as raised fasting 
plasma glucose, high blood pressure, high cholesterol 
(elevated triglycerides, low level of high density 
lipoprotein) and abdominal obesity. [5] Cardiovascular 
disease is a common comorbidity in type 2 diabetes 
mellitus. Globally, during 2018 cardiovascular 
disease affects approximately 32.2% of all persons 
with type 2 diabetes. [6]  
Diabetic dyslipidaemia in India is one among 
the top five causes of mortality. [7] The coexistence of 
dyslipidaemia and type 2 diabetes is a major 
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contributor to the development and progression of 
macro vascular complications in individuals with 
diabetes. The coexistence of dyslipidaemia and type 2 
diabetes is a major contributor to the development 
and progression of macro vascular complications in 
individuals with diabetes. 
Since, metabolic syndrome has become major 
cause of morbidity and mortality, identifying its 
cause and prevention has gained immense 
importance. The objective of this study is to 
determine the prevalence of individual components 
of metabolic syndrome and to identify the most 
critical predictive risk factors in Madhumegam (Type 
2 Diabetes mellitus) patients. This study will also 
elucidate the risk factors of metabolic syndrome with 
respect to age, gender, duration of disease and 
demographic details of the patients with 
Madhumegam. 
MATERIALS AND METHODS 
Sampling 
 A hospital based cross sectional study was 
conducted between May 2019 and July 2019. One 
hundred (100) participants with previously 
diagnosed type 2 diabetes from Ayothidoss Pandithar 
Hospital, National Institute of Siddha were 
purposively recruited in the study. The study was 
approved by Institutional Ethical Committee, 
National Institute of Siddha (IEC No. NIS/IEC/2019/ 
M-2). 
Socio Demographic Data   
Information on demographic and clinical 
characteristics such as age, gender, duration of 
diabetes, family history of diabetes, physical activity, 
occupation, smoking and alcohol consumption were 
collected using a questionnaire and participants 
medical records. 
Biochemical Parameters 
Biochemical parameters of participants were 
collected from their laboratory reports which was 
already taken within a month. The biochemical 
parameters included the lipid profile (total 
cholesterol, triglycerides, high density lipoprotein 
and low density lipoprotein in milligrams per 
decilitre) and fasting plasma glucose (milligrams per 
decilitre).  
Anthropometric Variables 
Waist circumference (centimeters) was 
measured using a measuring tape midway between 
the inferior angle of ribs and the suprailiac crest. 
Participants height (centimeters) and weight 
(kilograms) were also been measured. Body Mass 
Index (BMI) was calculated by dividing weight by 
height in metre squared (m2). 
Blood Pressure  
Blood pressure was recorded using a 
sphygmomanometer. Participant’s systolic and 
diastolic blood pressure was recorded in sitting 
position in the left arm with the arm supported at 
heart level and feet flat on the floor. Two readings 
were taken 5 minutes apart and the mean of the two 
was taken as blood pressure. 
Metabolic Syndrome criteria 
As per International Diabetes Federation, a 
person to be defined as having the metabolic 
syndrome they must have, Waist circumference ≥90 
cm in men or ≥80 cm in women (South Asians) and 
any two of the following four factors 1.Raised TG 
levels: ≥150 mg/dl, or specific treatment for this lipid 
abnormality 2.Reduced HDL: cholesterol <40 mg/dl 
in males and <50 mg/dl in females 3.Raised blood 
pressure: systolic BP ≥130 or diastolic BP ≥85 mmHg 
4.Raised fasting plasma glucose: ≥100 mg/dl or 
previously diagnosed diabetes. [5] 
Statistical Analysis 
 The statistical software statistical product 
and service solutions (SPSS) will be used for the 
analysis of the data and Microsoft word and Excel 
will be used to generate graphs and tables. 
RESULTS 
General Characteristics of the Population  
 The study population comprises of 100 type 2 
diabetes mellitus patients with 55 males (55.0%) and 
45 females (45.0%). The participants were found to 
be predominantly in the age group between 60-69 
(47%) while least in the age group of 30-39(6%). The 
subjects were residing more highly in urban (69%) 
followed by rural (17%) and least in semi urban 
(14%). 7% and 8% of the participants were smokers 
and consume alcohol respectively but none of the 
female were found. The subject with high pressure 
was found to be 39%. 
Prevalence of Metabolic Syndrome and its 
individual components 
The overall percentage prevalence of 
metabolic syndrome was 53%. Males had a lower 
percentage prevalence of 45.3% compared to a 
higher percentage prevalence of 54.7% for the female 
(fig.1). 
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Fig.1: Prevalence of metabolic syndrome in male and female participants 
 With respect to age, individual within the age group of 60-69 had highest prevalence of metabolic 
syndrome while age group of 30-39 has least prevalence of metabolic syndrome. The overall mean age of the 
population was 59.17 whereas the mean age of the population with metabolic syndrome was 57.85 (table 1). 
Table 1: Age wise distribution of metabolic syndrome among male and female population 
Age Male (n = 24) (%) Female (n = 29) (%) Total (n = 53) (%) 
30 – 39 0 (0) 3 (100) 3 (5.7) 
40 – 49 2 (33.3) 4 (66.7) 6 (11.3) 
50 – 59 7 (43.7) 9 (56.3) 16 (30.2) 
60 – 69 10 (47.6) 11 (52.4) 21 (39.6) 
70 + 5 (71.4) 2 (28.6) 7 (13.2) 
Total 24 29 53 
Majority of the participants with metabolic syndrome were residing in urban (62.3%) followed by 
similar percentage (18.9%) in rural and semi urban. Among the study population, metabolic syndrome was 
highly found in the physically inactive (37.7%) group compared with the moderately active (35.8%) and least 
present in the highly active (26.4%) group (fig.2). 
 
Fig.2: Relationship between metabolic syndrome and physical activity among study population 
The study found that mixed diet consuming participants were more prone to metabolic syndrome 
(81.1%) compared with the group consuming vegetarian diet (18.9%). Elevated triglyceride was found to be 
present in 77.3% of participants and present predominantly in female (51.2%) compared with the male 
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(48.8%). Lowered high density lipoprotein was found in 51% of participants with metabolic syndrome and 
more prevalent in female (63%) compared with the male (37%) (Table 2).  
 For overall study population with metabolic syndrome, abdominal obesity was the most common 
component followed by elevated triglyceride (77.3%) and lowered HDL (51%). In male the most common 
component was elevated triglyceride (48.8%) followed by abdominal obesity (45.3%) and elevated fasting 
glucose (45.3%). 
Table 2: Gender wise prevalence of individual components of metabolic syndrome 
Parameter Male (n = 55) (%) Female (n = 45) (%) Total (n = 100) (%) 
Abdominal obesity 24(45.3) 29(54.7) 53(100) 
Elevated fasting glucose 24(45.3) 29(54.7) 53(100) 
Elevated triglyceride 20(48.8) 21(51.2) 41(77.3) 
Lowered high 
Density lipoprotein 
10(37.0) 17(63) 27(51.0) 
Metabolic syndrome 24(45.3) 29(54.7) 53(100) 
 Similarly, in female subjects lowered HDL was most prevalent component (63%) followed by 
abdominal obesity (54.7%) and elevated fasting glucose (54.7%). Total cholesterol and elevated LDL were the 
only components that showed statistically significant difference between males and females. With respect to 
age, individual within the age group of 60-69 had highest prevalence of metabolic syndrome while age group of 
30-39 has least prevalence of metabolic syndrome. The overall mean age of the population was 59.17 whereas 
the mean age of the population with metabolic syndrome was 57.85. 
 Prevalence of metabolic syndrome found to be more in the in the participants having type 2 diabetes 
duration between 1 to 9 years. The least prevalence of metabolic syndrome was found in the participants 
having type 2 diabetes more than 30 years. The result shows that participants with hypertension has higher 
prevalence of metabolic syndrome (58.5%) compared with participants without hypertension (41.5%) (fig.3). 
  
Fig.3: Prevalence of metabolic syndrome among hypertensive and non-hypertensive participants 
The metabolic syndrome was more prevalent in the participants with overweight (BMI:25.0–29.9). 
None of the participants was found to be underweight. The participants with normal BMI (18.5 - 24.9) had 
more risk of metabolic syndrome compared with obese BMI (more than 30) (fig.4). 
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Fig.4: Distribution of BMI among the study population with metabolic syndrome 
The participants with metabolic syndrome who are following Siddha system of medicine was 37.7%. 
Participants with metabolic syndrome following both Siddha and Allopathy system of medicine for diabetes 
were 62.3%.  
DISCUSSION 
 Despite the increasing prevalence of 
metabolic syndrome, limited studies have been 
reported in India[8,9] in specific none of the studies 
has been documented in Tamilnadu. In gender 
category, females had higher prevalence of metabolic 
syndrome (54.7%) as they had more of the risk 
factors contributing to metabolic syndrome, 
compared to males (45.0%) which was similar with a 
previous study.[10,11] Subjects living in urban areas are 
more prone to metabolic syndrome compared with 
semi urban and rural areas and this coincides with 
previous report.[8] Briefly, urban subjects were 3 
times more likely to have metabolic syndrome than 
rural subjects and the reason may be due to a 
relatively sedentary lifestyle.  
From Table1, 39.6% of the 60-69 age group 
and 30.2% of the 50-59 age group had higher 
incidence of metabolic syndrome irrespective of 
gender. So, preventive measures should be taken for 
subjects in the above age groups since the prevalence 
of metabolic syndrome increases with age group 
above 50. [12] 
Previous study has recorded significantly 
higher measurements of abdominal obesity among 
the females with type 2 diabetes compared to their 
male counterparts.[13] This could partially be 
attributed to the lower cut-off for waist 
circumference and higher cut-off for HDL in women 
as compared to men. 
Compared to previous studies in Indian 
subcontinent with diabetes, one of the strengths of 
the current study is that revealed the subject 
following the Siddha and allopathy system of 
medicine, relative effect of vegetarian and mixed diet 
and duration of diabetes with effect on metabolic 
syndrome. 
The atherogenic lipid parameters were found 
to be higher among the female participants compared 
to their male counterparts but not significant which 
was similar to previous study.[14] The limitations of 
the study are hospital-based and cross-sectional 
study. 
CONCLUSION 
  Elevated triglyceride for men and lowered 
HDL for women were the strongest risk factors of 
metabolic syndrome in this study. Metabolic 
syndrome is a significant health problem and its 
preventive strategies should focus on early diagnoses 
and lifestyle modification.  
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